Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms

Journal of Neuroimmunology

Volumn 74, Issue 1-2, 1997, Pages 149-158

  Gaur, Amitabh ^a   Boehme, Stefen A ^a   Chalmers, Derek ^a   Crowe, Paul D ^a   Pahuja, Anil ^a   Ling, Nicholas ^a   Brocke, Stefan ^b   Steinman, Lawrence ^b   Conlon, Paul J ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

altered peptide ligands; autoimmunity; cytokines; experimental autoimmune encephalomyelitis; immunotherapy; multiple sclerosis; myelin basic protein; Th1 Th2

Indexed keywords

CYTOKINE; EPITOPE; MYELIN BASIC PROTEIN; SYNTHETIC PEPTIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ETIOLOGY; FEMALE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CELL DEATH; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; RECURRENCE; T-LYMPHOCYTES;

EID: 0030973661     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00220-2     Document Type: Article

References (40)

1. Abbas, A.K. (1996). Die and let live: Eliminating dangerous lymphocytes. Cell 84, 655-657.
2. Boehme, S.A., Zheng, L. and Lenardo, M.J. (1995). Analysis of the CD4 coreceptor and activation-induced costimulatory molecules in antigen-mediated mature T-lymphocyte death. J. Immunol. 155, 1703-1712.
3. Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankenstein, T., Martin, R., Utz, U., Karin, N., Mitchell, D., Veromaa, T., Waisman, A., Gaur, A., Conlon, P., Ling, N., Fairchild, P.J., Wraith, D.C., O'Garra, A., Fathman, C.G. and Steinman, L. (1996). Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379, 343-376.
4. Critchfield, J.M., Racke, M.K., Zuniga-Pflucker, J.C., Cannella, B., Raine, C.S., Goverman, J. and Lenardo, M.J. (1994). T-cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263, 1139-1143.
5. Clayton, J.P., Gammon, G.M., Ando, D.G., Kono, D.H., Hood, L. and Sercarz, E.E. (1989). Peptide-specific prevention of experimental allergic encephalomyelitis: Neonatal tolerance induced to the dominant T-cell determinant of myelin basic protein. J. Exp. Med. 169, 1681-1691.
6. Evavold, B.D. and Allen, P.M. (1991). Separation of IL-4 production from Th cell proliferation by an altered T-cell receptor ligand. Science 252, 1308-1310.
7. Forsthuber, T., Yip, H.C. and Lehmann, P.V. (1996). Induction of TH1 and TH2 immunity in neonatal mice. Science 271, 1728-1730.
8. Franco, A., Southwood, S., Arrhenius, T., Kuchroo, V.K., Grey, H.M., Sette, A. and Ishioka, G.Y. (1994). T-cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis. Eur. J. Immunol. 24, 940-946.
9. Gaur, A., Wiers, B., Liu, A., Rothbard, J.B. and Fathman, C.G. (1992). Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258, 1491-1494.
10. Gaur, A. and Fathman, C.G. (1994). Immunotherapeutic strategies directed at the trimolecular complex. Adv. Immunol. 56, 219-265.
11. Gold, D.P., Vainiene, M., Celnik, B., Wiley, S., Gibbs, C., Hashim, G.A., Vandenbark, A.A. and Offner, H. (1992). Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. II. Biased T-cell receptor V beta expression predominates in spinal cord infiltrating T-cells. J. Immunol. 148, 1712-1717.
12. Hogquist, K.A., Jameson, S.C., Heath, W.R., Howard, J.L., Bevan, M.J. and Carbone, F.R. (1994). T-cell receptor antagonist peptides induce positive selection. Cell 76, 17-27.
13. Hsieh, C.S., Macatonia, S.E., Tripp, C.S., Wolf, S.F., O'Garra, A. and Murphy, K.M. (1993). Development of TH1 CD4+ T-cells through IL-12 produced by listeria-induced macrophages. Science 260, 547-549.
14. Karin, N., Mitchell, D.J., Brocke, S., Ling, N. and Steinman, L. (1994). Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T-cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production. J. Exp. Med. 180, 2227-2237.
15. Martin, R., Jaraquemada, D., Flerlage, M., Richert, J., Whitaker, J., Long, E.G., McFarlin, D.E. and McFarland, H.F. (1990). Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T-cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145, 540-548.
16. Nicholson, L.B., Greer, J.M., Sobel, R.A., Lees, M.B. and Kuchroo, V.K. (1995). An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3, 397-405.
17. Oksenberg, J.R., Panzara, M.A., Begovich, A.B., Mitchell, D., Erlich, H.A., Murray, R.S., Shimonkevitz, R., Sherritt, M., Rothbard, J., Bernard, C.C. et al. (1993). Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362, 68-70.
18. Ota, K., Matsui, M., Milford, E.L., Mackin, G.A., Weiner, H.L. and Hafler, D.A. (1990). T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346, 183-187.
19. Page, D.M., Alexander, J., Snoke, K., Appella, E., Sette, A., Hedrick, S.M. and Grey, H.M. (1994). Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists. Proc. Natl. Acad. Sci. USA 91, 4057-4061.
20. Paul, W.E. and Seder, R.A. (1994). Lymphocyte responses and cytokines. Cell 76, 241-251.
21. Pfeiffer, C., Stein, J., Southwood, S., Ketelaar, H., Sette, A. and Bottomly, K. (1995). Altered peptide ligands can control CD4 T-lymphocyte differentiation in vivo. J. Exp. Med. 181, 1569-1574.
22. Racke, M.K., Bonomo, A., Scott, D.E., Cannella, B., Levine, A., Raine, C.S., Shevach, E.M. and Rocken, M. (1994). Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180, 1961-1966.
23. Ruberti, G., Gaur, A., Fathman, C.G. and Livingstone, A.M. (1991). The T-cell receptor repertoire influences V beta element usage in response to myoglobin. J. Exp. Med. 174, 83-92.
24. Sakai, K., Sinha, A.A., Mitchell, D.J., Zamvil, S.S., Rothbard, J.B., McDevitt, H.O. and Steinman, L. (1988a). Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. Proc. Natl. Acad. Sci. USA 85, 8608-8612.
25. Sakai, K., Zamvil, S.S., Mitchell, D.J., Lim, M., Rothbard, J.B. and Steinman, L. (1988b). Characterization of a major encephalitogenic T-cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J. Neuroimmunol. 19, 21-32.
26. Sakai, K., Zamvil, S.S., Mitchell, D.J., Hodgkinson, S., Rothbard, J.B. and Steinman, L. (1989). Prevention of experimental encephalomyelitis with peptides that block interaction of T-cells with major histocompatibility complex proteins. Proc. Natl. Acad. Sci. USA 86, 9470-9474.
27. Sloan-Lancaster, J., Evavold, B.D. and Allen, P.M. (1993). Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363, 156-159.
28. Sloan-Lancaster, J., Evavold, B.D. and Allen, P.M. (1994). Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med. 180, 1195-205.
29. Smilek, D.E., Wraith, D.C., Hodgkinson, S., Dwivedy, S., Steinman, L. and McDevitt, H.O. (1991). A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 88, 9633-9637.
30. Steinman, L., Waisman, A. and Altmann, D. (1995). Major T-cell responses in multiple sclerosis. Mol. Med. Today 1, 79-83.
31. Street, N.E. and Mosmann, T.R. (1991). Functional diversity of T-lymphocytes due to secretion of different cytokine patterns. Faseb J. 5, 171-177.
32. Swain, S.L. (1993). IL4 dictates T-cell differentiation. Res. Immunol. 144, 616-620.
33. Valli, A., Sette, A., Kappos, L., Oseroff, C., Sidney, J., Miescher, G., Hochberger, M., Albert, E.D. and Adorini, L. (1993). Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T-cells from multiple sclerosis patients. J. Clin. Invest. 91, 616-628.
34. Whitham, R.H., Bourdette, D.N., Hashim, G.A., Herndon, R.M., Ilg, R.C., Vandenbark, A.A. and Offner, H. (1991a). Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 146, 101-107.
35. Whitham, R.H., Jones, R.E., Hashim, G.A., Hoy, C.M., Wang, R.Y., Vandenbark, A.A. and Offner, H. (1991b). Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)Fl mice. J. Immunol. 147, 3803-3808.
36. Windhagen, A., Scholz, C., Hollsberg, P., Fukaura, H., Sette, A. and Hafler, D.A. (1995). Modulation of cytokine patterns of human autoreactive T-cell clones by a single amino acid substitution of their peptide ligand. Immunity 2, 373-380.
37. Wraith, D.C., Smilek, D.E., Mitchell, D.J., Steinman, L. and McDevitt, H.O. (1989). Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59, 247-255.
38. Wucherpfennig, K.W., Zhang, J., Witek, C., Matsui, M., Modabber, Y., Ota, K. and Hafler, D.A. (1994). Clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide. J. Immunol. 152, 5581-5592.
39. Zamvil, S.S. and Steinman, L. (1990). The T-lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8, 579-621.
40. Zhang, J., Markovic-Plese, S., Lacet, B., Raus, J., Weiner, H.L. and Hafler, D.A. (1994). Increased frequency of interleukin 2-responsive T-cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179, 973-984.